Pancreatic cancer Doctors Abroad — Page 4

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Specializes in pancreatic cancer at Medical Park Antalya, trained at Akdeniz University's prestigious medical oncology program.

• Completed medical oncology specialization in 2018
• Works at Antalya's leading Medical Park hospital complex
• Over 20 years of experience of medical experience
• Former roles at university teaching hospitals

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Ozden brings over 27 years of experience of medical experience, specializing in pancreatic cancer treatment at VM Medical Park Pendik Hospital.

• Graduated from Istanbul University's prestigious Cerrahpaşa Faculty of Medicine
• Completed Medical Oncology subspecialty at Kocaeli University
• Extensive experience in internal medicine before specializing in oncology

Dr. Auala Hubert is Head of the Gastrointestinal Cancer Center at Hadassah Medical Center – a leader focused on treating cancers of the digestive system, including pancreatic cancer.

• 36 years of experience of specialized experience in oncology and radiotherapy
• Leads a dedicated multidisciplinary cancer center at a top university hospital
• Board-certified in both medical oncology and radiotherapy
• Active member of the national Committee for Gastrointestinal Cancer
• Holds dual degrees in medicine and psychology

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Professor Yoram Kluger specializes in oncosurgery at Rambam Medical Center, focusing on pancreatic cancer cases.

• Professor with extensive surgical experience in oncology
• Works at Rambam Medical Center, a key healthcare provider
• Specialized in complex tumor removal procedures

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Professor Kyu Taek Lee specializes in pancreatic, bile duct, and gallbladder cancers at Samsung Medical Center.

• Gastroenterology specialist at Samsung Medical Center
• Trained at Stanford University School of Medicine
• Member of The Korean Society of Gastrointestinal Endoscopy

Prof. Jong Kyun Lee is among the best gastroenterologists in South Korea and Asia, specializing in pancreatic, bile duct, and gallbladder cancers.

• Gastroenterologist at Samsung Medical Center
• Trained at Seoul National University and the University of California
• Member of The Korean Society of Gastrointestinal Endoscopy and The Korean Pancreatobiliary Association

Professor Lim Do Hoon leads the Radiation Oncology Department at Samsung Medical Center, specializing in pancreaticobiliary cancer.

• Trained at Seoul National University College of Medicine
• Specialty training at Samsung Medical Center and Seoul National University Hospital
• Expert in stomach and pancreaticobiliary cancers
• Also treats CNS tumors, pediatric tumors, sarcomas, and hematologic cancers

Dr. Dong Wook Choi specializes in pancreatic cancer at Samsung Medical Center, with training from top institutions in the US and Japan.

• Fellowship at University of Pittsburgh, a leader in surgical oncology
• Member of the International Association of Hepato Biliary Pancreatic Surgery
• Active in the Korean Pancreas Surgery Club
• Residency and internship at Seoul National University Hospital

Dr. Antonio de Lacy Fortuny has performed over 15,000 surgical procedures, pioneering minimally invasive techniques globally.

• Specializes in gastrointestinal surgeries, including pancreatic cancer treatments
• Performs 1,000+ minimally invasive procedures annually
• President of the Association of Surgeons-Endoscopists in Europe
• Pioneer of TaTME technique for rectal cancer

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Tamar Jablonski-Perec completed a key oncology internship at the renowned Sloan-Kettering Cancer Center in New York.

• Head of the Institute of Oncology at Hadassah Medical Center
• Led the Breast Cancer Treatment Center and is a Professor of Oncology
• Doctor of Medical Sciences from Hebrew University in Jerusalem
• Member of several international cancer societies
• Awarded a scholarship from Hadassah Medical School